Market Place
Sourcing Support
Mylan`s Generic Cabazitaxel Receives Approval in the U.S.
05 Jul 2023 //
FDA
Sanofi prevails over Sandoz in Jevtana patent case
30 Jun 2023 //
FIERCE PHARMA
Accord`s Generic Cabazitaxel Receives Approval in the U.S.
26 Oct 2022 //
FDA
Natco Pharma`s partner Breckenridge gets FDA nod for prostate cancer drug
25 Jul 2022 //
ECONOMIC TIMES
Accord healthcare`s Generic Cabazitaxel Receives Approval in the US
08 Jun 2022 //
FDA
Apotex`s Generic Cabazitaxel Receives Approval in the U.S.
03 Feb 2022 //
FDA
Dr. Reddy`s Generic Cabazitaxel Receives Approval in the U.S.
20 Dec 2021 //
FDA
Starpharma reports positive Phase II interim data for prostate cancer
27 Nov 2021 //
CLINICALTRIALSARENA
Starpharma releases positive DEP® phase 2 interim results in prostate cancer
27 Nov 2021 //
PRNEWSWIRE
AstraZeneca scraps midphase drugs from $1B buyout, Heptares pact
13 Nov 2021 //
FIERCEBIOTECH
USPTO grants patent for DEP cabazitaxel in PII clinical-stage cancer treatments
15 Sep 2021 //
PRNEWSWIRE
EVER Pharma gains EU marketing authorization for value-added Cabazitaxel
21 Oct 2020 //
PRESS RELEASE
Sanofi`s Jevtana doubles progression-free survival in metastatic castration
02 Oct 2019 //
PRESS RELEASE
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC
29 Aug 2019 //
PATENT DOCS
Sanofi patent case win holds off generic rivals for key cancer drug
16 Aug 2019 //
PMLIVE
Sanofi defends top oncology drug with Jevtana patent win
16 Aug 2019 //
FIERCE PHARMA
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection
15 Sep 2018 //
EDQM
Apotex Inc.’s Generic Cabazitaxel Receives Tentative Approval In US
17 Jul 2018 //
FDA
BPI Labs Llc Generic Cabazitaxel Receives Approval In US
24 May 2018 //
FDA
Swayed by a discount, NICE backflips on Sanofi`s oral Gaucher med Cerdelga
01 Jun 2017 //
FIERCE PHARMA
Global move against Roche brings focus back on cancer drug prices
16 Feb 2017 //
THE HINDU BUSINESS LINE
Apotex`s Generic Cabazitaxel Receives Approval In US
26 Jan 2017 //
FDA
Scottish Medicines Consortium Okays Sanofi Prostate Cancer Drug
13 Dec 2016 //
NASDAQ
Accord’s Generic Cabazitaxel Receives Tentative Approval In US
24 Oct 2016 //
FDA
OncoGenex Announce Ph3 AFFINITY Trial with Custirsen Continue Interim Analyses
01 Dec 2015 //
PR NEWS WIRE
Patient survey finds pharma falls short on drug pricing
10 Jun 2015 //
PM LIVE
Sanofi’s Jevtana given last-minute CDF reprieve
26 May 2015 //
PHARMATIMES
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Sanofi for its ANDA Cabazitaxel Solution; IV (Infusion) (Jevtana®)
16 Feb 2015 //
BRECKENRIDGE PHARMACEUTICAL, INC.
NATCO Announces USFDA Filings for Fingolimod
10 Feb 2015 //
NATCO
25 Cancer Drugs to Be Denied on NHS
12 Jan 2015 //
THE TELEGRAPH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.